Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 120

1.

Palmoplantar Pustulosis and Allergies: A Systematic Review.

Brunasso Vernetti AMG, Puntoni M, Massone C.

Dermatol Pract Concept. 2019 Apr 30;9(2):105-110. doi: 10.5826/dpc.0902a05. eCollection 2019 Apr.

2.

Randomized Placebo Controlled Trial of Low-Dose Tamoxifen to Prevent Local and Contralateral Recurrence in Breast Intraepithelial Neoplasia.

DeCensi A, Puntoni M, Guerrieri-Gonzaga A, Caviglia S, Avino F, Cortesi L, Taverniti C, Pacquola MG, Falcini F, Gulisano M, Digennaro M, Cariello A, Cagossi K, Pinotti G, Lazzeroni M, Serrano D, Branchi D, Campora S, Petrera M, Buttiron Webber T, Boni L, Bonanni B.

J Clin Oncol. 2019 Apr 11:JCO1801779. doi: 10.1200/JCO.18.01779. [Epub ahead of print]

PMID:
30973790
3.

Role of 18F-Choline Positron Emission Tomography/Computed Tomography to Detect Structural Relapse in High-Risk Differentiated Thyroid Cancer Patients.

Piccardo A, Trimboli P, Puntoni M, Foppiani L, Treglia G, Naseri M, Bottoni GL, Massollo M, Sola S, Ferrarazzo G, Bruzzone M, Catrambone U, Arlandini A, Paone G, Ceriani L, Cabria M, Giovanella L.

Thyroid. 2019 Apr;29(4):549-556. doi: 10.1089/thy.2018.0552.

PMID:
30864903
4.

Sleep Quality among Police Officers: Implications and Insights from a Systematic Review and Meta-Analysis of the Literature.

Garbarino S, Guglielmi O, Puntoni M, Bragazzi NL, Magnavita N.

Int J Environ Res Public Health. 2019 Mar 11;16(5). pii: E885. doi: 10.3390/ijerph16050885. Review.

5.

The ASAMET trial: a randomized, phase II, double-blind, placebo-controlled, multicenter, 2 × 2 factorial biomarker study of tertiary prevention with low-dose aspirin and metformin in stage I-III colorectal cancer patients.

Petrera M, Paleari L, Clavarezza M, Puntoni M, Caviglia S, Briata IM, Oppezzi M, Mislej EM, Stabuc B, Gnant M, Bachleitner-Hofmann T, Roth W, Scherer D, Haefeli WE, Ulrich CM, DeCensi A.

BMC Cancer. 2018 Dec 4;18(1):1210. doi: 10.1186/s12885-018-5126-7.

6.

Pathogenesis of Leprosy: An Insight Into B Lymphocytes and Plasma Cells.

Fabel A, Giovanna Brunasso AM, Schettini AP, Cota C, Puntoni M, Nunzi E, Biondo G, Cerroni L, Massone C.

Am J Dermatopathol. 2019 Jun;41(6):422-427. doi: 10.1097/DAD.0000000000001310.

PMID:
30422829
7.

Development and Validation of a Self-Administered Multidimensional Prognostic Index to Predict Negative Health Outcomes in Community-Dwelling Persons.

Pilotto A, Veronese N, Quispe Guerrero KL, Zora S, Boone ALD, Puntoni M, Giorgeschi A, Cella A, Hidalgo IR, Pers YM, Ferri A, Fernandez JRH, Pisano Gonzalez M; EFFICHRONIC Consortium.

Rejuvenation Res. 2018 Dec 28. doi: 10.1089/rej.2018.2103. [Epub ahead of print]

PMID:
30382001
8.

Additional value of integrated 18F-choline PET/4D contrast-enhanced CT in the localization of hyperfunctioning parathyroid glands and correlation with molecular profile.

Piccardo A, Trimboli P, Rutigliani M, Puntoni M, Foppiani L, Bacigalupo L, Crescenzi A, Bottoni G, Treglia G, Paparo F, Del Monte P, Lanata M, Paone G, Ferrarazzo G, Catrambone U, Arlandini A, Ceriani L, Cabria M, Giovanella L.

Eur J Nucl Med Mol Imaging. 2019 Mar;46(3):766-775. doi: 10.1007/s00259-018-4147-4. Epub 2018 Sep 15.

PMID:
30219964
9.

Power of Absolute Values to Avoid Data Misinterpretations: The Case of Radioiodine-Induced Leukemia and Myelodysplasia.

Piccardo A, Puntoni M, Verburg FA, Luster M, Giovanella L.

J Clin Oncol. 2018 Jun 20;36(18):1880-1881. doi: 10.1200/JCO.2018.77.7318. Epub 2018 May 3. No abstract available.

PMID:
29723094
10.

Effects of oral amino acid supplementation on Multidimensional Prognostic Index in hospitalized older patients: a multicenter randomized, double-blind, placebo-controlled pilot study.

Volpato S, Custureri R, Puntoni M, Bianchi L, Daragjati J, Garaboldi S, Simonato M, Greco A, Rizzo E, Santo PD, Mangiacotti A, Zigoura E, Siri G, Pilotto A.

Clin Interv Aging. 2018 Apr 16;13:633-640. doi: 10.2147/CIA.S154998. eCollection 2018.

11.

Prognostic value of chromosomal imbalances, gene mutations, and BAP1 expression in uveal melanoma.

Patrone S, Maric I, Rutigliani M, Lanza F, Puntoni M, Banelli B, Rancati S, Angelini G, Amaro A, Ligorio P, Defferrari C, Castagnetta M, Bandelloni R, Mosci C, DeCensi A, Romani M, Pfeffer U, Viaggi S, Coviello DA.

Genes Chromosomes Cancer. 2018 Aug;57(8):387-400. doi: 10.1002/gcc.22541.

PMID:
29689622
12.

High Accumulation of Metformin in Colonic Tissue of Subjects With Diabetes or the Metabolic Syndrome.

Paleari L, Burhenne J, Weiss J, Foersch S, Roth W, Parodi A, Gnant M, Bachleitner-Hofmann T, Scherer D, Ulrich CM, Stabuc B, Puntoni M, Coccia G, Petrera M, Haefeli WE, DeCensi A.

Gastroenterology. 2018 Apr;154(5):1543-1545. doi: 10.1053/j.gastro.2017.12.040. Epub 2018 Mar 8. No abstract available.

13.

Biokinetic and dosimetric aspects of 64CuCl2 in human prostate cancer: possible theranostic implications.

Righi S, Ugolini M, Bottoni G, Puntoni M, Iacozzi M, Paparo F, Cabria M, Ceriani L, Gambaro M, Giovanella L, Piccardo A.

EJNMMI Res. 2018 Mar 1;8(1):18. doi: 10.1186/s13550-018-0373-9.

14.

Could short thyroid hormone withdrawal be an effective strategy for radioiodine remnant ablation in differentiated thyroid cancer patients?

Piccardo A, Puntoni M, Ferrarazzo G, Foppiani L, Bottoni G, Altrinetti V, Treglia G, Naseri M, Dib B, Cabria M, Trimboli P, Massollo M, Giovanella L.

Eur J Nucl Med Mol Imaging. 2018 Jul;45(7):1218-1223. doi: 10.1007/s00259-018-3955-x. Epub 2018 Feb 19.

PMID:
29460027
15.

64CuCl2 PET/CT in Prostate Cancer Relapse.

Piccardo A, Paparo F, Puntoni M, Righi S, Bottoni G, Bacigalupo L, Zanardi S, DeCensi A, Ferrarazzo G, Gambaro M, Ruggieri FG, Campodonico F, Tomasello L, Timossi L, Sola S, Lopci E, Cabria M.

J Nucl Med. 2018 Mar;59(3):444-451. doi: 10.2967/jnumed.117.195628. Epub 2017 Sep 8.

16.

Approval rating and opinion of outpatients and general practitioners toward generic drugs: a questionnaire-based real-world study.

Mattioli F, Siri G, Castelli F, Puntoni M, Zuccoli ML, Stimamiglio A, Martelli A.

Patient Prefer Adherence. 2017 Aug 18;11:1423-1433. doi: 10.2147/PPA.S126486. eCollection 2017.

17.

Grading and outcome prediction of pediatric diffuse astrocytic tumors with diffusion and arterial spin labeling perfusion MRI in comparison with 18F-DOPA PET.

Morana G, Piccardo A, Tortora D, Puntoni M, Severino M, Nozza P, Ravegnani M, Consales A, Mascelli S, Raso A, Cabria M, Verrico A, Milanaccio C, Rossi A.

Eur J Nucl Med Mol Imaging. 2017 Nov;44(12):2084-2093. doi: 10.1007/s00259-017-3777-2. Epub 2017 Jul 27.

PMID:
28752225
18.

Is CT perfusion helpful in the treatment allocation of patients with acute ischemic stroke? An expert-opinion analysis.

Strada L, Streifler JY, Del Sette B, Puntoni M, Castaldi A, Bianchini D, Del Sette M.

Neurol Sci. 2017 Oct;38(10):1771-1777. doi: 10.1007/s10072-017-3051-1. Epub 2017 Jul 19.

PMID:
28726048
19.

Clinical benefit and risk of death with endocrine therapy in ovarian cancer: A comprehensive review and meta-analysis.

Paleari L, Gandini S, Provinciali N, Puntoni M, Colombo N, DeCensi A.

Gynecol Oncol. 2017 Sep;146(3):504-513. doi: 10.1016/j.ygyno.2017.06.036. Epub 2017 Jul 10. Review.

20.

Worry and risk perception of breast cancer in a prevention trial of low dose tamoxifen in midlife postmenopausal hormone users.

Rondanina G, Puntoni M, Guerrieri-Gonzaga A, Marra D, Bonanni B, DeCensi A.

Breast. 2017 Aug;34:108-114. doi: 10.1016/j.breast.2017.05.008. Epub 2017 May 29.

PMID:
28570956
21.

Analysis of Serum Cholesterol Efflux Capacity in a Minipig Model of Nonischemic Heart Failure.

Bigazzi F, Adorni MP, Puntoni M, Sbrana F, Lionetti V, Pino BD, Favari E, Recchia FA, Bernini F, Sampietro T.

J Atheroscler Thromb. 2017 Aug 1;24(8):853-862. doi: 10.5551/jat.37101. Epub 2016 Dec 15.

22.

Differentiated Thyroid Cancer lymph-node relapse. Role of adjuvant radioactive iodine therapy after lymphadenectomy.

Piccardo A, Puntoni M, Bottoni G, Treglia G, Foppiani L, Bertoli M, Catrambone U, Arlandini A, Dib B, Altrinetti V, Massollo M, Bossert I, Cabria M, Bertagna F, Giovanella L.

Eur J Nucl Med Mol Imaging. 2017 Jun;44(6):926-934. doi: 10.1007/s00259-016-3593-0. Epub 2016 Dec 14.

PMID:
27966046
23.

Association of Biomarkers with Serious Cardiac Adverse Events during Abiraterone Acetate Treatment in Castration Resistant Prostate Cancer.

Campora S, Campazzi E, Zanardi S, Puntoni M, Piccininno M, Piccardo A, Shoushtari Zadeh Naseri M, Defferrari C, Provinciali N, Petrera M, Marra D, Biscaldi E, Antonucci GC, Ricci D, Clavarezza M, Gennari A, Gozza A, D'Amico M, Mori M, DeCensi A.

Transl Oncol. 2016 Dec;9(6):600-605. doi: 10.1016/j.tranon.2016.08.001. Review.

24.

Phenotypic variability in 4 homozygous familial hypercholesterolemia siblings compound heterozygous for LDLR mutations.

Rabacchi C, Bigazzi F, Puntoni M, Sbrana F, Sampietro T, Tarugi P, Bertolini S, Calandra S.

J Clin Lipidol. 2016 Jul-Aug;10(4):944-952.e1. doi: 10.1016/j.jacl.2016.04.005. Epub 2016 Apr 21.

PMID:
27578127
25.

Frailty is associated with socioeconomic and lifestyle factors in community-dwelling older subjects.

Poli S, Cella A, Puntoni M, Musacchio C, Pomata M, Torriglia D, Vello N, Molinari B, Pandolfini V, Torrigiani C, Pilotto A.

Aging Clin Exp Res. 2017 Aug;29(4):721-728. doi: 10.1007/s40520-016-0623-5. Epub 2016 Aug 27.

PMID:
27568018
26.

Dual Block with Lapatinib and Trastuzumab Versus Single-Agent Trastuzumab Combined with Chemotherapy as Neoadjuvant Treatment of HER2-Positive Breast Cancer: A Meta-analysis of Randomized Trials.

Clavarezza M, Puntoni M, Gennari A, Paleari L, Provinciali N, D'Amico M, DeCensi A.

Clin Cancer Res. 2016 Sep 15;22(18):4594-603. doi: 10.1158/1078-0432.CCR-15-1881. Epub 2016 May 2.

27.

Prognostic Significance of VEGF after Twenty-Year Follow-up in a Randomized Trial of Fenretinide in Non-Muscle-Invasive Bladder Cancer.

Puntoni M, Petrera M, Campora S, Garrone E, Defferrari C, Torrisi R, Johansson H, Bruno S, Curotto A, DeCensi A.

Cancer Prev Res (Phila). 2016 Jun;9(6):437-44. doi: 10.1158/1940-6207.CAPR-15-0345. Epub 2016 Apr 4.

28.

Repurposing old drugs to chemoprevention: the case of metformin.

Heckman-Stoddard BM, Gandini S, Puntoni M, Dunn BK, DeCensi A, Szabo E.

Semin Oncol. 2016 Feb;43(1):123-133. doi: 10.1053/j.seminoncol.2015.09.009. Epub 2015 Sep 8. Review.

29.

Thyroid nodules with indeterminate cytology: prospective comparison between 18F-FDG-PET/CT, multiparametric neck ultrasonography, 99mTc-MIBI scintigraphy and histology.

Piccardo A, Puntoni M, Treglia G, Foppiani L, Bertagna F, Paparo F, Massollo M, Dib B, Paone G, Arlandini A, Catrambone U, Casazza S, Pastorino A, Cabria M, Giovanella L.

Eur J Endocrinol. 2016 May;174(5):693-703. doi: 10.1530/EJE-15-1199. Epub 2016 Mar 10.

PMID:
26966173
30.

Ability of (18)F-DOPA PET/CT and fused (18)F-DOPA PET/MRI to assess striatal involvement in paediatric glioma.

Morana G, Puntoni M, Garrè ML, Massollo M, Lopci E, Naseri M, Severino M, Tortora D, Rossi A, Piccardo A.

Eur J Nucl Med Mol Imaging. 2016 Aug;43(9):1664-72. doi: 10.1007/s00259-016-3333-5. Epub 2016 Feb 25.

PMID:
26911489
31.

PIK3CA Mutation, Aspirin Use after Diagnosis and Survival of Colorectal Cancer. A Systematic Review and Meta-analysis of Epidemiological Studies.

Paleari L, Puntoni M, Clavarezza M, DeCensi M, Cuzick J, DeCensi A.

Clin Oncol (R Coll Radiol). 2016 May;28(5):317-26. doi: 10.1016/j.clon.2015.11.008. Epub 2015 Dec 17. Review.

PMID:
26712086
32.

Diagnostic and prognostic value of 18F-DOPA PET and 1H-MR spectroscopy in pediatric supratentorial infiltrative gliomas: a comparative study.

Morana G, Piccardo A, Puntoni M, Nozza P, Cama A, Raso A, Mascelli S, Massollo M, Milanaccio C, Garrè ML, Rossi A.

Neuro Oncol. 2015 Dec;17(12):1637-47. doi: 10.1093/neuonc/nov099. Epub 2015 Sep 23.

33.

Effect of Metformin on Breast Ductal Carcinoma In Situ Proliferation in a Randomized Presurgical Trial.

DeCensi A, Puntoni M, Guerrieri-Gonzaga A, Cazzaniga M, Serrano D, Lazzeroni M, Vingiani A, Gentilini O, Petrera M, Viale G, Cuzick J, Bonanni B, Pruneri G.

Cancer Prev Res (Phila). 2015 Oct;8(10):888-94. doi: 10.1158/1940-6207.CAPR-15-0048. Epub 2015 Aug 14.

34.

Relationship among IL-6, LDL cholesterol and lipid peroxidation.

Lubrano V, Gabriele M, Puntoni MR, Longo V, Pucci L.

Cell Mol Biol Lett. 2015 Jun;20(2):310-22. doi: 10.1515/cmble-2015-0020.

PMID:
26204410
35.

18F-FDG PET/CT is a prognostic biomarker in patients affected by bone metastases from breast cancer in comparison with 18F-NaF PET/CT.

Piccardo A, Puntoni M, Morbelli S, Massollo M, Bongioanni F, Paparo F, Altrinetti V, Gonella R, Gennari A, Iacozzi M, Sambuceti G, DeCensi A.

Nuklearmedizin. 2015;54(4):163-72. doi: 10.3413/Nukmed-0727-15-02. Epub 2015 Jul 13.

PMID:
26165806
36.

Breast cancer incidence after hormonal treatments for infertility: systematic review and meta-analysis of population-based studies.

Gennari A, Costa M, Puntoni M, Paleari L, De Censi A, Sormani MP, Provinciali N, Bruzzi P.

Breast Cancer Res Treat. 2015 Apr;150(2):405-13. doi: 10.1007/s10549-015-3328-0. Epub 2015 Mar 6. Review.

PMID:
25744295
37.

Modulation of lipid homeostasis in response to continuous or intermittent high-fat diet in pigs.

Puccinelli E, Gervasi PG, Trivella MG, Vornoli A, Viglione F, Pelosi G, Parodi O, Sampietro T, Puntoni M.

Animal. 2015 Jun;9(6):1000-7. doi: 10.1017/S1751731114003292. Epub 2015 Feb 4.

PMID:
25649276
38.

Detection of biomarkers for inflammatory diseases by an electrochemical immunoassay: the case of neopterin.

Centi S, Tombelli S, Puntoni M, Domenici C, Franek M, Palchetti I.

Talanta. 2015 Mar;134:48-53. doi: 10.1016/j.talanta.2014.10.053. Epub 2014 Nov 4.

PMID:
25618639
39.

Differential effects of metformin on breast cancer proliferation according to markers of insulin resistance and tumor subtype in a randomized presurgical trial.

DeCensi A, Puntoni M, Gandini S, Guerrieri-Gonzaga A, Johansson HA, Cazzaniga M, Pruneri G, Serrano D, Schwab M, Hofmann U, Mora S, Aristarco V, Macis D, Bassi F, Luini A, Lazzeroni M, Bonanni B, Pollak MN.

Breast Cancer Res Treat. 2014 Nov;148(1):81-90. doi: 10.1007/s10549-014-3141-1. Epub 2014 Sep 25.

40.

An observational study of nasal cavity toxicity in cancer patients treated with bevacizumab.

D'Amico M, Pagano M, Pasa A, Puntoni M, Clavarezza M, Gennari A, Gozza A, Zanardi S, Defferrari C, Provinciali N, Campazzi E, Campora S, Paleari L, Marra D, Petrera M, DeCensi A.

Expert Opin Drug Saf. 2014 Nov;13(11):1437-42. doi: 10.1517/14740338.2014.960388. Epub 2014 Sep 16.

PMID:
25224760
41.

CT of the abdomen: degree and quality of enhancement obtained with two concentrations of the same iodinated contrast medium with fixed iodine delivery rate and total iodine load.

Paparo F, Garello I, Bacigalupo L, Marziano A, Galletto Pregliasco A, Rollandi L, Puppo C, Mattioli F, Puntoni M, Rollandi GA.

Eur J Radiol. 2014 Nov;83(11):1995-2000. doi: 10.1016/j.ejrad.2014.07.010. Epub 2014 Aug 12.

PMID:
25174776
42.

Extrusion of the medial meniscus in knee osteoarthritis assessed with a rotating clino-orthostatic permanent-magnet MRI scanner.

Paparo F, Revelli M, Piccazzo R, Astengo D, Camellino D, Puntoni M, Muda A, Rollandi GA, Garlaschi G, Cimmino MA.

Radiol Med. 2015 Apr;120(4):329-37. doi: 10.1007/s11547-014-0444-6. Epub 2014 Aug 13.

PMID:
25115292
43.

Determination of deferasirox plasma concentrations: do gender, physical and genetic differences affect chelation efficacy?

Mattioli F, Puntoni M, Marini V, Fucile C, Milano G, Robbiano L, Perrotta S, Pinto V, Martelli A, Forni GL.

Eur J Haematol. 2015 Apr;94(4):310-7. doi: 10.1111/ejh.12419. Epub 2014 Sep 17.

PMID:
25081908
44.

Metformin and cancer risk and mortality: a systematic review and meta-analysis taking into account biases and confounders.

Gandini S, Puntoni M, Heckman-Stoddard BM, Dunn BK, Ford L, DeCensi A, Szabo E.

Cancer Prev Res (Phila). 2014 Sep;7(9):867-85. doi: 10.1158/1940-6207.CAPR-13-0424. Epub 2014 Jul 1. Review.

45.

¹⁸F-FDG uptake as a prognostic variable in primary differentiated thyroid cancer incidentally detected by PET/CT: a multicentre study.

Piccardo A, Puntoni M, Bertagna F, Treglia G, Foppiani L, Arecco F, Giubbini R, Naseri M, Cistaro A, Cabria M, Bardesono F, Ceriani L, Orlandi F, Giovanella L.

Eur J Nucl Med Mol Imaging. 2014 Aug;41(8):1482-91. doi: 10.1007/s00259-014-2774-y. Epub 2014 Apr 30.

PMID:
24781870
46.

Inflammation blood and tissue factors of plaque growth in an experimental model evidenced by a systems approach.

Pelosi G, Rocchiccioli S, Cecchettini A, Viglione F, Puntoni M, Parodi O, Capobianco E, Trivella MG.

Front Genet. 2014 Apr 7;5:70. doi: 10.3389/fgene.2014.00070. eCollection 2014.

47.

Early senescence in heterozygous ABCA1 mutation skin fibroblasts: a gene dosage effect beyond HDL deficiency?

Puntoni M, Bigazzi F, Sabatino L, Sbrana F, Musio A, Dal Pino B, Ragusa A, Corsano E, Sampietro T.

Biochem Biophys Res Commun. 2014 May 2;447(2):231-6. doi: 10.1016/j.bbrc.2014.03.090. Epub 2014 Mar 26.

PMID:
24680682
48.

Value of 18F-3,4-dihydroxyphenylalanine PET/MR image fusion in pediatric supratentorial infiltrative astrocytomas: a prospective pilot study.

Morana G, Piccardo A, Milanaccio C, Puntoni M, Nozza P, Cama A, Zefiro D, Cabria M, Rossi A, Garrè ML.

J Nucl Med. 2014 May;55(5):718-23. doi: 10.2967/jnumed.113.125500. Epub 2014 Mar 20.

49.

Intravesical mitomycin C combined with local microwave hyperthermia in non-muscle-invasive bladder cancer with increased European Organization for Research and Treatment of Cancer (EORTC) score risk of recurrence and progression.

Maffezzini M, Campodonico F, Canepa G, Manuputty EE, Tamagno S, Puntoni M.

Cancer Chemother Pharmacol. 2014 May;73(5):925-30. doi: 10.1007/s00280-014-2423-y. Epub 2014 Mar 1.

PMID:
24585046
50.

Prognostic value of ¹⁸F-DOPA PET/CT at the time of recurrence in patients affected by neuroblastoma.

Piccardo A, Puntoni M, Lopci E, Conte M, Foppiani L, Sorrentino S, Morana G, Naseri M, Cistaro A, Villavecchia G, Fanti S, Garaventa A.

Eur J Nucl Med Mol Imaging. 2014 Jun;41(6):1046-56. doi: 10.1007/s00259-014-2691-0. Epub 2014 Feb 22.

PMID:
24562643

Supplemental Content

Loading ...
Support Center